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Introduction

v Breast density can be defined as, “a measure
used to describe the proportion of
fibroglandular tissue in a woman’s breast
depicted on a digital mammogram” (Mohamed
2018, pg. 315).
v In 1992, the Mammography Quality Standards
Act (MSQA) was enacted to ensure that all
women would have access to quality
mammography for the detection of breast
cancer in its earliest, most treatable stages
(Center, About the Mammography Program,
2018).
v For the past 25 years, the Mammography
Quality Standards Act has required
mammography facilities to send each patient a
written summary of the mammography report in
lay terms. The MQSA requires that the written
summary must be sent within 30 days of the
mammogram and if the patient’s mammogram
is interpreted as “Suspicious” or “Highly
Suggestive of Malignancy”, the facility must
make reasonable attempts to communicate
these results to the patient and the referring
healthcare provider (Center, Direct-To-Patient
Mammogram Results, 2018).
v In additional to the MQSA requirements, the
Breast Density Notification Law was created,
with 38 states passing the law since January
2020.
v The Breast Density Notification Legislature
states that within the written summary of the
mammogram results, the patient’s breast
density using the American College of
Radiology categories must be included for
patients to be aware of their own density
(Department, 2019).
v Although state legislature has increased
women’s knowledge on the topic of breast
density and the risks associated with it, it has
also brought on challenges for physicians.
Primary physicians need education on best
practices for management and when the patient
should be referred for ultrasound imaging.
v Research has show that women with a higher
breast density are at an increased risk for
developing breast cancer (Moothathu, 2017).
v A limitation associated with mammography is
that microcalcifications, which are often the
findings suspicious for early diagnosis of breast
malignancies, can be obscured by higher breast
density (Moothathu, 2017).
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v Mammography is optimal for comparing the
ratio of fat to fibroglandular tissue of the breast.
It is considered the best screening tool for
breast composition and abnormalities.
Mammography requires low-dose ionizing
radiation in order to evaluate the breast tissue
and is cost efficient. Breast tissue with higher
density are more difficult to penetrate creating
more to detect abnormalities or masses.
(Biomarker, 2015). Digital breast tomosynthesis,
or 3D mammography, has increased the
sensitivity of detection of subtle findings.
Tomosynthesis uses an electronic detector
system to obtain multiple projection images
which are synthesized by the computer to create
thin slices of the breast tissue. This allows the
radiologist the ability to scroll through the
images, reducing tissue overlap and providing
earlier detection of abnormalities that may be
masked during conventional mammography
(Hooley, 2017). Mammography is often
complimented by ultrasound and MRI to further
characterize areas of suspicion or confirm the
composition of the lesion.

v Breast Sonography (ultrasound) is an
imaging modality which uses sound waves to
produce images of the internal structures of the
breast. Ultrasound is currently the most widely
utilized supplemental imaging modality
appropriate for women with dense breasts and
intermediate or average risk, as well as women
with a very high-risk (Moothathu, 2017).
Ultrasound can better differentiate fluid filled
lesions from solid tissue lesions and document
characteristics associated with benign versus
malignant lesions. Advancing technology and
automated breast ultrasound system (ABUS) is
a more current technology standardizing breast
ultrasound imaging of the whole breast, reduces
operator dependency, and allows physicians to
school through all breast tissue. Breast
ultrasound is widely available, well tolerated by
patients, relatively inexpensive, and can detect
small, less than 1 cm in size, invasive
mammographically occult malignancies
(Moothathu, 2017).
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Sonography Limitations
(Abbreviated, 2018)

Mammography Limitations
v Mammographic sensitivity decreases with
increasing breast density. This is primarily due to
the masking effect of the fibroglandular breast
tissue, which can obscure an underlying
malignancy (Zhao, 2015).
v False-negative results. Overall, screening
mammograms do not find abut 1 in every 5
breast malignancies (Zhao, 2015).
v Mammography cannot determine the exact size
and location of an abnormality (Zhao, 2015).

v Not sensitive to microcalcifications.
Microcalcifications may be present on the
mammographic images but not the ultrasound
images (Kawamura, 2018).
v Conventional sonography is user dependent, if
the sonographer is to miss an area while
scanning, a potential abnormality could be
missed (Kawamura, 2018).
v Length of time required to scan an entire
breast. More commonly only the suspicious
quadrant or area of the breast is scanned
rather than the entire breast (Kawamura,
2018).
v ABUS is available and less user dependent but
it is underutilized.

v The BI-RADS mammographic breast density
criteria include four qualitative categories of
breast density:
1. Almost entirely fatty
• Approximately 10% of women
2. Scattered areas of fibroglanduar density
• Approximately 40% of women
3. Heterogeneously dense
• Approximately 40% of women
4. Extremely dense
• Approximately 10% of women
(Mohamed, 2018)

(Dense, 2018)

Conclusion
v Due to the increased risk of breast cancer
associated with breast density, it is essential
women are knowledgeable on the topic of
breast density. It is also important that
physicians are informing patients on their
breast density category and referring them for
additional imaging exams if necessary.
Although there are limitations associated with
both mammography and breast sonography,
using supplemental screening tools is the best
way to evaluate a potential breast abnormality.
According to a study performed in 2018, 90%
of the women agreed that they would prefer to
know their breast tissue type. It also showed
that having a breast density reporting law
enacted by the state increased the likelihood
that a women learned their breast tissue type
from a mammogram results letter and health
care providers spoke with women about
receiving supplemental screening (Cappello,
2019). If all states were to pass the Breast
Density Notification Legislature, more women
would become informed on the risks
associated with breast density. Breast density
awareness could be improved because of the
enactment of the Breast Density Notification
Legislature, therefore reducing the number of
women affected by undetected early staged
breast cancer.

